Use of carnitines and resveratrol in the preparation of a composition for the prevention or therapeutic treatment of cerabral disorders caused by aging and the use of neurotoxic drugs

摘要

A pharmaceutical product which comprises admixed or separately packaged (A) L-Carnitine or an alkanoyl L-canitine and (B) a trihydroxy- or tetrahydroxystilbene such as resveratrol is useful for the prevention and treatment of pathological neuronal or cerebral disorders.